Syneron Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $150M

  • Investors
  • 16

Syneron General Information

Description

Developer of peptide therapeutics designed to accelerate the discovery and development of novel drug candidates. The company offers peptide design capabilities, high-throughput screening systems, and predictive property algorithms, enabling pharmaceutical developers to streamline early-stage research and improve drug development efficiency.

Contact Information

Website
www.syneronbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 2 Ruitai Road, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 132
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Number 2 Ruitai Road, Huangpu District
  • Guangzhou, Guangdong 510000
  • China
+86 132

Syneron Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syneron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC (Series B) 31-Mar-2026 $150M Completed Generating Revenue
6. Early Stage VC (Series A1) 11-Dec-2025 Completed Generating Revenue
5. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
4. Early Stage VC (Series A) 15-Nov-2024 Completed Generating Revenue
3. Early Stage VC 13-Mar-2023 Completed Generating Revenue
2. Seed Round 25-Jul-2022 Completed Startup
1. Seed Round 19-May-2022 Completed Startup
To view Syneron’s complete valuation and funding history, request access »

Syneron Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTrack Capital Venture Capital Minority
CDH Investments PE/Buyout Minority
Decheng Capital Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
5Y Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Syneron FAQs

  • When was Syneron founded?

    Syneron was founded in 2022.

  • Where is Syneron headquartered?

    Syneron is headquartered in Guangzhou, China.

  • What industry is Syneron in?

    Syneron’s primary industry is Drug Discovery.

  • Is Syneron a private or public company?

    Syneron is a Private company.

  • What is Syneron’s current revenue?

    The current revenue for Syneron is .

  • How much funding has Syneron raised over time?

    Syneron has raised $250M.

  • Who are Syneron’s investors?

    BioTrack Capital, CDH Investments, Decheng Capital, Qiming Venture Partners, and 5Y Capital are 5 of 16 investors who have invested in Syneron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process